K-pop

BTS and BLACKPINK Receive Additional Nominations for the U.S. MTV VMAs

BTS Nominated in a Total of 3 Categories To be held on the 27th at the Peacock Theater in Los Angeles, U.S.

Gim Ga Yeong
2026-09-19 15:02:29
[Edaily Starin Gim Ga Yeong Reporter] Groups such as BTS and BLACKPINK have been added to the list of nominees for the “2026 MTV Video Music Awards” (MTV VMAs), a U.S. pop music awards ceremony.
According to the official MTV VMA website on the 18th (local time), BTS, Blackpink, Cortes, and Cat’s Eye have been nominated in the “Best Group” category.
In the “Best Song of the Summer” category, Cat’s Eye’s “HOOTIE FRUTTI” and “DRACULA”—a collaboration between BLACKPINK’s Jennie and Australian singer Tame Impala—were nominated.
In addition to the newly announced “Best Group” category, BTS has been nominated in a total of three categories, including “Song of the Year” and “Best K-Pop.” BTS has won the “Best Group” trophy for four consecutive years, from 2019 to 2022.
In addition, Cortis has been nominated in three categories—'Best New Artist,' 'Best K-Pop,' and 'Best Group'—while Cat’s Eye has been nominated in four categories: 'Best Choreography,' 'Best K-Pop,' 'Best Group,' and 'Best Song of the Summer.'
The MTV VMAs will be held on the 27th at the Peacock Theater in Los Angeles, USA.

Economy

Corporation

IT·Science

Economy

[VC's Pick] The AI That Played a Match Against Lee Sedol 9-dan… Enhance Secures 51.2 Billion Investment

This week (September 14–18), startups in various fields—including medical artificial intelligence (AI), content solutions, and content tech—secured investments from venture capital (VC) firms and acce…
2026-09-19 09:21:04

Corporation

Kang Seong-min, CEO of PeopleBio, Inc.: “Full-Scale Launch of LDT and Diagnostic Kit Business in the U.S. … Revenue to Become Apparent Starting Next Year”

“Building on our designation as an innovative medical device by the U.S. Food and Drug Administration (FDA), we plan to establish a local subsidiary within this year. Next year, we will launch laborat…
2026-09-19 08:07:02

IT·Science

Opacalim Clinical Trials Paused… A Closer Look at the Preconditions for SK BIOPHARMACEUTICALS’s 2.3 Trillion Won Deal

SK BIOPHARMACEUTICALS(326030)has drawn attention by repeatedly emphasizing that the deal to acquire “Opacalym” (BHV-7000), a new drug candidate for epilepsy, from the U.S. biotech company Biohaven is …
2026-09-19 08:41:01